France vs Puerto Rico: The number of people with susceptibility test result for rifampicin
France
17
in 2021
Puerto Rico
14
in 2021
France rank
134th
Puerto Rico rank
136th
The number of people with susceptibility test result for rifampicin over time
- France
- Puerto Rico
How they compare
France currently reports 17 against 14 in Puerto Rico, a difference of 3.
That makes France's figure about 1.2 times Puerto Rico's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was France ahead.
France ranks 134th and Puerto Rico ranks 136th of 155 countries.
France has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | France | Puerto Rico | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,801 | 25.33 | 1,776 | France |
| 2020s | 18.5 | 18 | 0.5 | France |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, France or Puerto Rico?
- France, at 17 against 14 in Puerto Rico as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between France and Puerto Rico?
- 3, with France ahead.
- How many years of comparable data are there for France and Puerto Rico?
- 5 years are reported by both, from 2017 to 2021.
- How do France and Puerto Rico rank globally for the number of people with susceptibility test result for rifampicin?
- France ranks 134th and Puerto Rico ranks 136th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.